No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
253.41 MCAD
—
188.05
0.13CAD
−21.66 MCAD
28.68 MCAD
22.60 M
Beta (1Y)
0.52
About Fennec Pharmaceuticals Inc.
Sector
CEO
Rostislav C. Raykov
Headquarters
Durham
Website
Employees (FY)
29
Founded
1996
FIGI
BBG000BBWCT9
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
$FENC: Short setup$FENC has a nice short signal, the stock had a spectacular rally since it bottomed in early 2022, but could be reaching the end of the road here after drastically outperforming the market until now. Their drug received FDA approval in Sep 2022, commercial availability in the US in Oct 2022, but desp
Short
FENC Analysis - Dip Buy0.786 can be seen as a previous point of resistancenow that price has moved higher than this level, it will be seen as a point of support for the breakdown of the rising wedge , a pattern that is commonly bearish (as you can see on the chart)Pharmaceutical companies are possibly hot right now, due
FENC ShortThis is an opinion and not trading advice. FENC looks like a short here.
Short
WATCHING $FENC for ENTRY TARGET @ 5.68WATCHING $FENC for ENTRY TARGET @ 5.68If this gets to 5.68 I'll play... 😏
FENC BULLISHI like the MACD cross and the close above the 61.8% Fibonacci level after testing it twice before. Also we should see a "golden cross" as the 50SMA crosses the 200MA in the next week or so. This of course would be very bullish. 1st target 9.412nd target 10.18
Long
FENCBecause PHARMA.
Long
FENC1 bullish scenarioGreat r:r
Long
strange head and shoulders?
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Stock brokers
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Featured
4.4Very Good
Learn more
TradeStation
4.4Very Good
Learn more
Curated watchlists where FRX is featured.
Low-cap oncology stocks: Small companies fighting cancer
Frequently Asked Questions
The current price of
FRX
is
9.28
CAD
— it has decreased by
1.75
% in the past 24 hours. Watch
FENNEC PHARMACEUTICALS INC
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
TSX
exchange
FENNEC PHARMACEUTICALS INC
stocks are traded under the ticker
FRX
.
FRX
stock has fallen by
1.43
% compared to the previous week, the month change is a
13.96
% fall, over the last year
FENNEC PHARMACEUTICALS INC
has showed a
23.03
% decrease.
We've gathered analysts' opinions on
FENNEC PHARMACEUTICALS INC
future price: according to them,
FRX
price has a max estimate of
30.04
CAD
and a min estimate of
19.12
CAD
. Watch
FRX chartand read a more detailed
FENNEC PHARMACEUTICALS INC stock forecast: see what analysts think of
FENNEC PHARMACEUTICALS INC
and suggest that you do with its stocks.
FRX
reached its all-time high on
Apr 9, 2018
with the price of
18.86
CAD
, and its all-time low was
0.63
CAD
and was reached on
Sep 12, 2013
. View more price dynamics on
FRX chart.
See other stocks reaching their highest and lowest prices.
FRX
stock is
3.07
% volatile and has beta coefficient of
0.52
. Track
FENNEC PHARMACEUTICALS INC
stock price on the chart and check out the list of the most volatile stocks — is
FENNEC PHARMACEUTICALS INC
there?
Today
FENNEC PHARMACEUTICALS INC
has the market capitalization of
253.41 M
, it has increased by
6.00
% over the last week.
Yes, you can track
FENNEC PHARMACEUTICALS INC financialsin yearly and quarterly reports right on TradingView.
FENNEC PHARMACEUTICALS INC
is going to release the next earnings report on
Aug 9, 2024
. Keep track of upcoming events with our Earnings Calendar.
FRX
earnings for the last quarter are
0.56
CAD
per share, whereas the estimation was
−0.08
CAD
resulting in a
813.04
% surprise. The estimated earnings for the next quarter are
−0.03
CAD
per share. See more details about
FENNEC PHARMACEUTICALS INC earnings.
for the last quarter amounts to
34.38 M
CAD
, despite the estimated figure of
13.84 M
CAD
. In the next quarter, revenue is expected to reach
15.18 M
CAD
.
FRX
net income for the last quarter is
17.31 M
CAD
, while the quarter before that showed
−3.65 M
CAD
of net income which accounts for
573.92
% change. Track more
FENNEC PHARMACEUTICALS INC financial statsto get the full picture.
No,
FRX
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Jun 16, 2024
, the company has
29.00
employees. See our rating of the largest employees — is
FENNEC PHARMACEUTICALS INC
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
FENNEC PHARMACEUTICALS INC
EBITDA is
8.43 M
CAD
, and current EBITDA margin is
−60.09
%. See more stats in
FENNEC PHARMACEUTICALS INC financial statements.
Like other stocks,
FRX
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
FENNEC PHARMACEUTICALS INC
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
FENNEC PHARMACEUTICALS INC
technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
FENNEC PHARMACEUTICALS INC
stock shows the sell signal. See more of
FENNEC PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.